• Explore /
  • Poster
  • / A phase II study of neoadjuvant pembrolizumab and lenvatinib for resectable stage III melanoma: The neopele study.

A phase II study of neoadjuvant pembrolizumab and lenvatinib for resectable stage III melanoma: The neopele study.

Abstract Poster

Authors

null

Maria Gonzalez

Melanoma Institute Australia, North Sydney, Australia

Maria Gonzalez , Alexander M. Menzies , Thomas Pennington , Robyn PM Saw , Andrew J. Spillane , Jonathan Stretch , Kerwin Frank Shannon , Sydney Ch'ng , Omgo E. Nieweg , Maria Cruzado Rojas , Monica Osorio , Robert V Rawson , Peter M. Ferguson , Helen Rizos , Serigne Lo , Richard A. Scolyer , Georgina V. Long

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCTNCT04207086

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS10088)

DOI

10.1200/JCO.2020.38.15_suppl.TPS10088

Abstract #

TPS10088

Poster Bd #

437

Abstract Disclosures

Similar Posters

First Author: Judith M. Versluis

First Author: Irene L.M. Reijers

First Author: Irene L.M. Reijers

First Author: Minke W. Lucas